Enabling development, manufacturing, and regulatory approval of biotherapeutics through advances in mass spectrometry.

Apostol, Izydor; Bondarenko, Pavel V; Ren, Da; Semin, David J; Wu, Chao-Hsiang; Zhang, Zhongqi; Goudar, Chetan T

Apostol, Izydor; Bondarenko, Pavel V; Ren, Da; Semin, David J; Wu, Chao-Hsiang; Zhang, Zhongqi; Goudar, Chetan T.

Afiliação

Apostol I; Attribute Sciences, Process Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA 91320, United States.
Bondarenko PV; Attribute Sciences, Process Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA 91320, United States.
Ren D; Attribute Sciences, Process Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA 91320, United States.
Semin DJ; Attribute Sciences, Process Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA 91320, United States.
Wu CH; Attribute Sciences, Process Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA 91320, United States.
Zhang Z; Attribute Sciences, Process Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA 91320, United States.
Goudar CT; Attribute Sciences, Process Development, Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA 91320, United States. Electronic address: cgoudar@amgen.com.

Curr Opin Biotechnol ; 71: 206-215, 2021 10.

Article em En | MEDLINE | ID: mdl-34508981

Assuntos

Produtos Biológicos; Anticorpos Monoclonais/uso terapêutico; Produtos Biológicos/uso terapêutico; Espectrometria de Massas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos Idioma: En Revista: Curr Opin Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google